AvantiCell Science
About:
AvantiCell Science supplies cell-based products and services for pharmaceutical, agri-biotechnology, and healthcare industries.
Website: http://www.avanticell.com/
Twitter/X: avanticell
Top Investors: EASME - EU Executive Agency for SMEs
Description:
AvantiCell delivers leading-edge solutions for customers wishing to evaluate bio-activity or bio-safety in a wide-range of test materials; from pharmaceuticals, traditional medicines and natural products to medical devices and nano-structured materials. AvantiCell solutions use advanced cell culture technology based on physiologically-relevant human and animal cells. AvantiCell supplies a growing range of human primary cell products which are accessible as cell isolates requiring re-culture within the customer's laboratory or in the form of pre-assembled, cryopreserved models. These products make cell-based analysis available to all customers in a plug-and-play format. AvantiCell also provides its expertise in a range of services ranging from off-the-shelf cell-based assays to specialist cell culture systems customised to meet customers’ requirements. As leaders in cell culture, AvantiCell also offer client-commissioned production of unusual human primary cell types and development of customized analytical models.
1.31M EUR
$1M to $10M
Ayr, South Ayrshire, United Kingdom
2006-01-01
info(AT)avanticell.com
Colin Wilde
11-50
2015-11-01
Private
© 2025 bioDAO.ai